InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-16.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Goodwin Bradford S, Director. Director active across 2 companies, notably RIGEL PHARMACEUTICALS INC. Aggregated, 2 reports have been published. History available since 19 May 2021. The latest transaction was disclosed on 19 May 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations2 total
25,000 shares0Common StockSEC:0001179110-21-005771
25,000 shares0Common StockSEC:0001179110-21-005771:0
2 of 2 declarations
About Goodwin Bradford S
Bradford S. Goodwin is a Board Member at Rigel Pharmaceuticals Inc. He plays a key role in the governance of the company, contributing to the definition of its strategy and guiding its research efforts. His experience in the biopharmaceutical sector is valuable in guiding Rigel in its development initiatives.
